Zhi-Bin Wang - Search Results

Year	Number of Results
2003	5
2004	1
2005	3
2006	2
2007	3
2008	7
2009	7
2010	9
2011	9
2012	14
2013	10
2014	14
2015	11
2016	21
2017	9
2018	8
2019	14
2020	14
2021	17
2022	15
2023	14
2024	18
2025	14

1

Targeting EFHD2 inhibits interferon-γ signaling and ameliorates non-alcoholic steatohepatitis.

Fu JT, Liu J, Wu WB, Chen YT, Lu GD, Cao Q, Meng HB, Tong J, Zhu JH, Wang XJ, Liu Y, Zhuang C, Sheng C, Shen FM, Liu X, Wang H, Yu Y, Zhang Y, Liang HY, Zhang JB, Li DJ, Li X, Wang ZB, Wang P. Fu JT, et al. Among authors: wang zb. J Hepatol. 2024 Sep;81(3):389-403. doi: 10.1016/j.jhep.2024.04.009. Epub 2024 Apr 25. J Hepatol. 2024. PMID: 38670321

2

Roles of TRPM7 in ovarian cancer.

Wang ZB, Zhang X, Xiao F, Liu ZQ, Liao QJ, Wu N, Wang J. Wang ZB, et al. Biochem Pharmacol. 2023 Nov;217:115857. doi: 10.1016/j.bcp.2023.115857. Epub 2023 Oct 13. Biochem Pharmacol. 2023. PMID: 37839677 Free article. Review.

3

Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer.

Xiao F, Wang Z, Qiao L, Zhang X, Wu N, Wang J, Yu X. Xiao F, et al. J Transl Med. 2024 Aug 21;22(1):778. doi: 10.1186/s12967-024-05583-z. J Transl Med. 2024. PMID: 39169400 Free PMC article. Review.

4

Phytochemistry and pharmacology of genus Ephedra.

Zhang BM, Wang ZB, Xin P, Wang QH, Bu H, Kuang HX. Zhang BM, et al. Among authors: wang zb. Chin J Nat Med. 2018 Nov;16(11):811-828. doi: 10.1016/S1875-5364(18)30123-7. Chin J Nat Med. 2018. PMID: 30502763 Review.

5

Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy.

Wang ZB, Zhang X, Fang C, Liu XT, Liao QJ, Wu N, Wang J. Wang ZB, et al. Immunology. 2024 Sep;173(1):14-32. doi: 10.1111/imm.13793. Epub 2024 Apr 15. Immunology. 2024. PMID: 38618976 Review.

6

Unveiling the shield: Troglitazone's impact on epilepsy-induced nerve injury through ferroptosis inhibition.

Wang ZB, Liu JY, Jiang SL, Zhuo W, Xie P, Dai WT, Mao XY, Liu ZQ. Wang ZB, et al. CNS Neurosci Ther. 2024 Aug;30(8):e14911. doi: 10.1111/cns.14911. CNS Neurosci Ther. 2024. PMID: 39145422 Free PMC article.

7

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more.

Wang ZB, Liu D, Lei G, Liu ZQ, Wu N, Wang J. Wang ZB, et al. Front Pharmacol. 2023 Jun 9;14:1222209. doi: 10.3389/fphar.2023.1222209. eCollection 2023. Front Pharmacol. 2023. PMID: 37361211 Free PMC article. No abstract available.

8

Alkaloids in Chelidonium majus L: a review of its phytochemistry, pharmacology and toxicology.

Li XL, Sun YP, Wang M, Wang ZB, Kuang HX. Li XL, et al. Among authors: wang zb. Front Pharmacol. 2024 Aug 22;15:1440979. doi: 10.3389/fphar.2024.1440979. eCollection 2024. Front Pharmacol. 2024. PMID: 39239653 Free PMC article. Review.

9

Danggui-Shaoyao-San: New Hope for Alzheimer's Disease.

Fu X, Wang Q, Wang Z, Kuang H, Jiang P. Fu X, et al. Aging Dis. 2015 Dec 20;7(4):502-13. doi: 10.14336/AD.2015.1220. eCollection 2016 Aug. Aging Dis. 2015. PMID: 27493835 Free PMC article. Review.

10

Familial atrial myxoma.

Sun P, Wang ZB. Sun P, et al. Among authors: wang zb. Cardiol Young. 2008 Oct;18(5):525-7. doi: 10.1017/S1047951108002692. Epub 2008 Aug 18. Cardiol Young. 2008. PMID: 18706136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Results by year